Chemed Corp (CHE) carries a Roarable Rating of C+ (Hold) with 69/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Chemed Corp (CHE) advanced +1.61% to $541.92 as options desks priced 58% call premium vs. 42% put protection around the $531 max-pain magnet. Solid 33% profit margin (23% return on capital), mixed timing at 185x P/E—hold if owned, no rush to chase.
Healthcare services company Chemed Corporation (NYSE:CHE) announced better-than-expected revenue in Q3 2026, with sales up 10.6% year on year to $690.9 million. Its non-GAAP profit of $6.75 per share was 4.9% above analy
Chemed (CHE) is back in focus after a strong third quarter, with higher profit, rising earnings per share and a guidance raise that, together with an analyst upgrade, has stirred fresh interest in the stock. Chemed’s rec
Chemed’s third quarter saw positive market reaction, with results surpassing Wall Street’s revenue and non-GAAP profit expectations. Management attributed the strong performance to robust admissions growth and cost contr
Chemed’s updated fair value estimate has shifted from US$571.60 to US$592.60, a change of about 3.7% in the latest analyst work. That move sits against a mixed research backdrop, with stronger Vitas expectations, a more
RBC Capital analyst Ben Hendrix maintains Chemed (NYSE:CHE) with a Sector Perform and raises the price target from $548 to $585.
UBS analyst A.J. Rice maintains Chemed (NYSE:CHE) with a Buy and raises the price target from $650 to $675.
Oppenheimer analyst Michael Wiederhorn maintains Chemed (NYSE:CHE) with a Outperform and raises the price target from $590 to $625.
Chemed (NYSE:CHE) reported higher third-quarter revenue and adjusted earnings as growth at its VITAS hospice business offset margin pressure at Roto-Rooter from customer-acquisition and fuel costs. President and Chief Ex
CINCINNATI (AP) — CINCINNATI (AP) — Chemed Corp. (CHE) on Tuesday reported profit of $71.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +65.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CHE today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CHE. Explore sector supply chains on /butterfly.
Why CHE Stock advanced +1.61% Today — RQD Quant Desk Flash. Solid 33% profit margin (23% return on capital), mixed timing at 185x P/E—hold if owned, no rush to chase.